Washington Trust Bancorp, Inc. (WASH) Forms $55.80 Double Top; Last Week Invuity, Inc. (IVTY) Analysts

Washington Trust Bancorp, Inc. (WASH) formed double top with $58.59 target or 5.00% above today’s $55.80 share price. Washington Trust Bancorp, Inc. (WASH) has $960.93M valuation. The stock increased 2.86% or $1.55 during the last trading session, reaching $55.8. About 45,373 shares traded or 37.22% up from the average. Washington Trust Bancorp, Inc. (NASDAQ:WASH) has risen 30.56% since January 21, 2017 and is uptrending. It has outperformed by 13.86% the S&P500.

Among 4 analysts covering Invuity Inc (NASDAQ:IVTY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invuity Inc had 7 analyst reports since August 29, 2016 according to SRatingsIntel. Northland Capital maintained Invuity, Inc. (NASDAQ:IVTY) rating on Wednesday, July 26. Northland Capital has “Buy” rating and $1300 target. The rating was maintained by Piper Jaffray on Tuesday, July 25 with “Buy”. As per Monday, August 29, the company rating was initiated by Craig Hallum. The rating was maintained by Northland Capital with “Buy” on Tuesday, June 13. The stock of Invuity, Inc. (NASDAQ:IVTY) has “Buy” rating given on Monday, September 19 by Lake Street. See Invuity, Inc. (NASDAQ:IVTY) latest ratings:

26/07/2017 Broker: Northland Capital Rating: Buy New Target: $13.0000 Maintain
25/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $10.0000 Maintain

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company has market cap of $91.70 million. The firm integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It currently has negative earnings. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries.

The stock decreased 0.93% or $0.05 during the last trading session, reaching $5.35. About 340,344 shares traded or 180.21% up from the average. Invuity, Inc. (NASDAQ:IVTY) has risen 50.92% since January 21, 2017 and is uptrending. It has outperformed by 34.22% the S&P500.

Investors sentiment increased to 1.31 in 2017 Q3. Its up 0.15, from 1.16 in 2017Q2. It is positive, as 7 investors sold Washington Trust Bancorp, Inc. shares while 28 reduced holdings. 15 funds opened positions while 31 raised stakes. 9.43 million shares or 0.20% less from 9.45 million shares in 2017Q2 were reported. Great West Life Assurance Co Can holds 0% or 1,871 shares. Geode Cap Mngmt Limited Liability reported 132,467 shares or 0% of all its holdings. Tiaa Cref Invest Mgmt Lc holds 0% or 42,652 shares. Boston Private Wealth Lc has invested 0.01% in Washington Trust Bancorp, Inc. (NASDAQ:WASH). Affinity Advsrs Ltd Liability Corp invested in 0.03% or 4,285 shares. Principal Fincl Inc accumulated 1.11M shares. Teachers Insur And Annuity Association Of America stated it has 0.03% of its portfolio in Washington Trust Bancorp, Inc. (NASDAQ:WASH). Renaissance Technology Ltd Liability invested 0.03% in Washington Trust Bancorp, Inc. (NASDAQ:WASH). 6,807 were accumulated by Millennium Management Ltd Liability. Raymond James And Assoc owns 67,468 shares for 0.01% of their portfolio. Pennsylvania-based Vanguard Gru Inc has invested 0% in Washington Trust Bancorp, Inc. (NASDAQ:WASH). 25,460 are held by Ny State Common Retirement Fund. 445,149 were reported by Manufacturers Life Insur The. Sg Americas Securities Ltd Liability Corp has invested 0% in Washington Trust Bancorp, Inc. (NASDAQ:WASH). 16,474 were reported by Aqr Capital Mgmt Limited Com.

Among 4 analysts covering Washington Trust Bancorp (NASDAQ:WASH), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Washington Trust Bancorp has $59.0 highest and $39.0 lowest target. $45.20’s average target is -19.00% below currents $55.8 stock price. Washington Trust Bancorp had 16 analyst reports since July 22, 2015 according to SRatingsIntel. As per Thursday, January 26, the company rating was upgraded by Compass Point. The company was upgraded on Wednesday, December 30 by Keefe Bruyette & Woods. As per Tuesday, September 20, the company rating was downgraded by Compass Point. Compass Point downgraded the stock to “Neutral” rating in Friday, November 18 report. The rating was upgraded by Compass Point to “Buy” on Tuesday, October 25. Compass Point upgraded Washington Trust Bancorp, Inc. (NASDAQ:WASH) rating on Wednesday, January 27. Compass Point has “Buy” rating and $41 target. On Tuesday, September 26 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Compass Point upgraded the stock to “Buy” rating in Monday, December 18 report. On Tuesday, October 24 the stock rating was downgraded by Compass Point to “Hold”. On Tuesday, October 20 the stock rating was maintained by Compass Point with “Neutral”.